Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Change in Cash (2016 - 2025)

Historic Change in Cash for Perspective Therapeutics (CATX) over the last 16 years, with Q3 2025 value amounting to -$2.1 million.

  • Perspective Therapeutics' Change in Cash rose 9189.29% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$199.7 million, marking a year-over-year decrease of 19587.23%. This contributed to the annual value of $52.2 million for FY2024, which is 54372.61% up from last year.
  • Perspective Therapeutics' Change in Cash amounted to -$2.1 million in Q3 2025, which was up 9189.29% from -$15.6 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Change in Cash registered a high of $132.9 million during Q1 2024, and its lowest value of -$164.9 million during Q4 2024.
  • Its 5-year average for Change in Cash is $1.0 million, with a median of -$6.3 million in 2022.
  • In the last 5 years, Perspective Therapeutics' Change in Cash surged by 722980.65% in 2021 and then tumbled by 178522.58% in 2024.
  • Perspective Therapeutics' Change in Cash (Quarter) stood at $37.9 million in 2021, then tumbled by 192.1% to -$34.9 million in 2022, then surged by 74.94% to -$8.7 million in 2023, then plummeted by 1785.23% to -$164.9 million in 2024, then surged by 98.73% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, -$15.6 million for Q2 2025, and -$17.2 million during Q1 2025.